My ePortfolio Register   

Circulating tumour cells in melanoma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.05.17
Views: 874

Dr Evi Lianidou - University of Athens, Athens, Greece

Dr Lianidou speaks with ecancer at EADO 2017 about the clinical utility of melanoma patient blood samples to gain insight into disease progression and genotype.

She describes how serial blood draws can be used to gain up-to-date insight into tumour biology, disease evolution over time, and the significance of determining new and known therapeutic targets.

Dr Lianidou highlights the significance of quality control throughout the acquisition and analysis of patient samples, and introduces the Cancer-ID initiative.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence